$225.77−4.14 (−1.80%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$225.09−0.68 (−0.30%)
After hours: Nov 17, 2026, 7:17 PM ET
Danaher (DHR) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~−0.2%/yr (FY21→FY25), net margin 14.7%, and free cash flow (~$5.3B) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($B)▲2.9%
24.6
FY21→FY25CAGR −0.2%/yr
Net income ($B)▼7.3%
3.6
FY21→FY25CAGR −13.4%/yr
Free cash flow ($B)▼0.7%
5.3
FY21→FY25CAGR −7.3%/yr
Diluted EPS▼4.5%
5.05
buyback-liftedCAGR −12.5%/yr
What the receipts whisper · what a headline number hides
Share count
−2.8%
736.8mn → 716.1mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$1.2B
−17.0% YoY in FY25 · 4.7% of revenue.
Returns vs FCF
75%
$4.0B returned vs $5.3B of FCF in FY25. Buybacks + dividends covered by cash flow.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)
15¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 61.4% → 59.1%. Net margin 14.7% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 25,608.0 | 24,568.0 | 23,875.0 | 23,890.0 | 26,643.0 | 24,802.0 | ▲2.9% | −0.2% |
Cost of revenue | 10,603.0 | 10,045.0 | 9,669.0 | 9,856.0 | 10,455.0 | 9,563.0 | ▲3.9% | +1.2% |
Gross profit | 15,005.0 | 14,523.0 | 14,206.0 | 14,034.0 | 16,188.0 | 15,239.0 | ▲2.2% | −1.2% |
Research & development | 1,670.0 | 1,598.0 | 1,584.0 | 1,503.0 | 1,528.0 | 1,498.0 | ▲0.9% | +1.6% |
Selling, general & admin | 8,117.0 | 8,235.0 | 7,759.0 | 7,329.0 | 7,124.0 | 7,364.0 | ▲6.1% | +2.8% |
Total operating expenses | 9,787.0 | 9,833.0 | 9,343.0 | 8,832.0 | 8,652.0 | 8,862.0 | ▲5.2% | +2.6% |
Operating incomefeeds ROC rank | 5,218.0 | 4,690.0 | 4,863.0 | 5,202.0 | 7,536.0 | 6,377.0 | ▼3.6% | −7.4% |
Other income, net | −400.0 | −457.0 | −217.0 | −158.0 | −390.0 | 134.0 | — | — |
Pretax income | 4,818.0 | 4,233.0 | 4,646.0 | 5,044.0 | 7,146.0 | 6,511.0 | ▼8.9% | −10.2% |
Income tax | 529.0 | 633.0 | 747.0 | 823.0 | 818.0 | 1,064.0 | ▼15.3% | −12.2% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 4,331.0 | 3,614.0 | 3,899.0 | 4,764.0 | 7,209.0 | 6,433.0 | ▼7.3% | −13.4% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 6.12 | 5.05 | 5.29 | 6.38 | 9.66 | 8.61 | ▼4.5% | −12.5% |
Diluted shares (mn) | 706.80 | 716.10 | 737.20 | 743.10 | 737.10 | 736.80 | ▼2.9% | −0.7% |
| Margins | ||||||||
Gross margin39th pct in Healthcare | 58.6% | 59.1% | 59.5% | 58.7% | 60.8% | 61.4% | ▼0.4pp | −2.3pp |
Operating margin | 20.4% | 19.1% | 20.4% | 21.8% | 28.3% | 25.7% | ▼1.3pp | −6.6pp |
Net margin80th pct in Healthcare | 16.9% | 14.7% | 16.3% | 19.9% | 27.1% | 25.9% | ▼1.6pp | −11.2pp |
† TTM = trailing four quarters through 2026-09-25.
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Danaher's revenue last fiscal year?
Danaher reported revenue of $24.6B in fiscal 2025, up 2.9% from fiscal 2024.
What was Danaher's net income?
Danaher reported net income of $3.6B in fiscal 2025, a net margin of 14.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

